Recent advances in the treatment of trichotillomania (hair-pulling disorder).

Dermatologic Therapy
Gregory J EverettJonathon Skurya

Abstract

Trichotillomania (TTM) is a condition in which affected individuals pull out their hair resulting in hair loss. This disorder affects roughly 0.5% to 2.0% of the population and can have significant psychological morbidity. Behavioral therapy has been used with success in the treatment of TTM, but not all patients are willing or able to comply with this treatment strategy. There is a need for effective pharmacological treatment options. Historically, pharmacotherapy for TTM has been inadequate in most cases, but recent advances have been made in this regard. Fluoxetine, clomipramine, olanzapine, and naltrexone have all been used in the treatment of TTM, but evidence of benefit has varied, and side effect profiles can limit practical utility. Recent advances in the understanding of the pathophysiology of TTM, as well as evidence of benefit seen with some glutamate-modulating agents such as N-acetylcysteine and dronabinol, have provided newer potential pharmacotherapy options.

References

Feb 1, 1992·The Journal of Clinical Endocrinology and Metabolism·S W LambertsF H de Jong
Mar 1, 2000·The Journal of Clinical Psychiatry·P T NinanM B Eccard
Mar 10, 2001·The Journal of Clinical Psychiatry·S SeedatB H Harvey
May 14, 2003·Archives of General Psychiatry·Agnes van MinnenGert-Jan Hendriks
Aug 31, 2007·Biological Psychiatry·Michael H BlochVladimir Coric
Aug 16, 2008·The New England Journal of Medicine·Raymond F Anton
Dec 20, 2008·Molecular Psychiatry·S ZüchnerD L Murphy
Mar 19, 2009·Journal of the American Academy of Dermatology·Mohammad JafferanyRobin L Hornung
Nov 21, 2009·Clinical Psychology Review·Danny C DukeEric A Storch
May 6, 2010·The Journal of Clinical Psychiatry·Michael Van AmeringenJonathan Oakman
Aug 20, 2010·Depression and Anxiety·Nancy J KeuthenMichael A Jenike
Dec 15, 2010·Anais Brasileiros De Dermatologia·Leonardo Spagnol AbrahamLuna Azulay-Abulafia
Feb 2, 2011·Proceedings of the National Academy of Sciences of the United States of America·Rochellys Diaz HeijtzSven Pettersson
Nov 10, 2011·Acta Dermato-venereologica·Jacinto Orgaz-MolinaSalvador Arias-Santiago
Dec 16, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Juan Undurraga, Ross J Baldessarini
Mar 5, 2013·Journal of the American Academy of Child and Adolescent Psychiatry·Michael H BlochJames F Leckman
Mar 5, 2013·Journal of the American Academy of Child and Adolescent Psychiatry·Kaitlyn E PanzaMichael H Bloch
Jun 14, 2013·Biological Psychiatry·Timothy G DinanJohn F Cryan
Aug 26, 2014·The Psychiatric Clinics of North America·Douglas W Woods, David C Houghton
Oct 2, 2014·The Journal of Clinical Psychiatry·Edson Luiz ToledoHermano Tavares
Apr 22, 2015·Psychology Research and Behavior Management·Ivar SnorrasonHan-Joo Lee
May 11, 2015·Neuroscience and Biobehavioral Reviews·DeepmalaRichard Frye
May 6, 2016·Journal of the European Academy of Dermatology and Venereology : JEADV·D Özcan, D Seçkin
Sep 2, 2016·The American Journal of Psychiatry·Jon E Grant, Samuel R Chamberlain
Nov 9, 2016·International Clinical Psychopharmacology·Eric W LeppinkJon E Grant
Feb 2, 2017·International Psychogeriatrics·Mairead M BartleyJon E Grant
Sep 28, 2017·Molecular Psychiatry·N NagarajanM R Capecchi
Sep 28, 2017·Anais Brasileiros De Dermatologia·Livia Ariane Lopes BarrosoGisele Jacobino de Barros Nunes
Nov 4, 2017·The Journal of Clinical Psychiatry·Lindsay Brauer, Jon E Grant
Mar 9, 2018·NeuroImage. Clinical·Masanori IsobeSamuel R Chamberlain
Apr 12, 2018·Anais Brasileiros De Dermatologia·Bianca Pinheiro Bousquet MuylaertCamila Raposo Cabral Scuotto
May 11, 2018·Free Radical Research·Giancarlo AldiniFrancesco Sergio
Jul 20, 2018·Cellular and Molecular Gastroenterology and Hepatology·Clair R MartinEmeran A Mayer
Jan 3, 2019·Psychiatry Investigation·Jon E Grant, Samuel R Chamberlain
Feb 13, 2019·Indian Journal of Psychiatry·Jon E Grant
Aug 2, 2019·Skin Appendage Disorders·Corina Isabel Salas-Callo, Rodrigo Pirmez

❮ Previous
Next ❯

Citations

May 25, 2021·The European Journal of Neuroscience·Diana SketrieneRobyn M Brown

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Journal of Cognitive Psychotherapy
Michael R WaltherDouglas W Woods
Seminars in Cutaneous Medicine and Surgery
Monica HuynhMichelle Magid
© 2022 Meta ULC. All rights reserved